Anders Hove
Partner & Founder @ Acorn Bioventures
New York, United States
Anders Hove is a Series C investor at Acorn Bioventures in New York focused on Health Care and Biotechnology. Anders Hove is the Partner and Founder at acorn Bioventures. Attended INSEAD.
- Total investments:
- 15
- Last investment:
- Lead investor:
- 33%
Last updated:
For AI agents: llms.txt
Industries Anders Hove invests in
Health CareBiotechnologyMedicalTherapeuticsPharmaceutical
Stages Anders Hove invests in
Series CSeries EFunding RoundSeries BSeries D
Countries Anders Hove invests in
United States
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Health Care 8 (53%)
- Biotechnology 6 (40%)
- Medical 4 (27%)
- Therapeutics 3 (20%)
- Pharmaceutical 3 (20%)
Stage
- Series C 4 (27%)
- Series E 2 (13%)
- Funding Round 2 (13%)
- Series B 1 (7%)
- Series D 1 (7%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Intuity Medical
|
Intuity Medical develops blood glucose monitoring systems for diabetes management. Their POGO Automatic Blood Glucose Monitoring System is the world’s first FDA-cleared automatic, one-step blood glucose meter that combines lancing, blood collection, and analysis into a single 10-test cartridge. It provides a convenient and discreet solution formillions of patients who need to regularly test their blood glucose.The company was founded in 2002 and is headquartered in Fremont, California. | $40M / Nov 10, 2016 | |
Edge Therapeutics
|
Edge Therapeutics is a clinical-stage biotechnology company that discovers, develops and seeks to commercialize novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological conditions. EG-1962, our lead product candidate, has the potential to fundamentally improve patientoutcomes and transform the management of aneurysmal subarachnoid hemorrhage, or aSAH, which is bleeding around the brain due to a ruptured brain aneurysm. EG-1964, our second product candidate, is being evaluated as a potential prophylactic treatment in the management of chronic subdural hematoma, to prevent recurrent bleeding on the surface of the brain.It was founded in 2009 and is headquartered in Berkeley Heights, New Jersey. | $56M / Series C / Apr 09, 2015 | |
Mevion Medical Systems
|
Mevion Medical Systems, Inc. (formerly Still River Systems, Inc.) is a radiation therapy company dedicated to advancing the treatment of cancer. As the pioneering developer of modern proton therapy systems, Mevion provides innovative, safe, and effective solutions by transforming advances in medical technology and science into practical clinicalreality.Mevion’s flagship product, the MEVION S250 Proton Therapy System, is designed to preserve all of the treatment benefits of traditional proton therapy systems while removing the obstacles of size, cost, and complexity. Realizing this vision, Mevion has forever changed the economics and accessibility of proton therapy worldwide.Founded in 2004, Mevion is a privately held company headquartered in the Boston metropolitan area with international offices in the United Kingdom and Japan. | $200M / Private Equity / Aug 04, 2014 | |
Coherus Biosciences
|
Coherus Biosciences is a biopharmaceutical company that engages in the development, manufacture, and commercialization of biologic therapeutics. The company develops biologic medicines primarily for the treatment of oncology and inflammatory diseases. It focuses on process science, analytical characterization, protein production, andclinical-regulatory development. Its pipeline includes Immunology, anti-tumor necrosis factor (Anti-TNF) biosimilar candidates; Ophthalmology biosimilar candidates; and Oncology Biosimilar candidates. | $54.7M / Series C / May 19, 2014 | |
|
Intuity Medical
|
Intuity Medical develops blood glucose monitoring systems for diabetes management. Their POGO Automatic Blood Glucose Monitoring System is the world’s first FDA-cleared automatic, one-step blood glucose meter that combines lancing, blood collection, and analysis into a single 10-test cartridge. It provides a convenient and discreet solution formillions of patients who need to regularly test their blood glucose.The company was founded in 2002 and is headquartered in Fremont, California. | $5.5M / Jan 30, 2014 | |
|
Mevion Medical Systems
|
Mevion Medical Systems, Inc. (formerly Still River Systems, Inc.) is a radiation therapy company dedicated to advancing the treatment of cancer. As the pioneering developer of modern proton therapy systems, Mevion provides innovative, safe, and effective solutions by transforming advances in medical technology and science into practical clinicalreality.Mevion’s flagship product, the MEVION S250 Proton Therapy System, is designed to preserve all of the treatment benefits of traditional proton therapy systems while removing the obstacles of size, cost, and complexity. Realizing this vision, Mevion has forever changed the economics and accessibility of proton therapy worldwide.Founded in 2004, Mevion is a privately held company headquartered in the Boston metropolitan area with international offices in the United Kingdom and Japan. | $55M / Private Equity / Jun 25, 2013 | |
|
Intuity Medical
|
Intuity Medical develops blood glucose monitoring systems for diabetes management. Their POGO Automatic Blood Glucose Monitoring System is the world’s first FDA-cleared automatic, one-step blood glucose meter that combines lancing, blood collection, and analysis into a single 10-test cartridge. It provides a convenient and discreet solution formillions of patients who need to regularly test their blood glucose.The company was founded in 2002 and is headquartered in Fremont, California. | $12M / Aug 09, 2012 | |
|
Mevion Medical Systems
|
Mevion Medical Systems, Inc. (formerly Still River Systems, Inc.) is a radiation therapy company dedicated to advancing the treatment of cancer. As the pioneering developer of modern proton therapy systems, Mevion provides innovative, safe, and effective solutions by transforming advances in medical technology and science into practical clinicalreality.Mevion’s flagship product, the MEVION S250 Proton Therapy System, is designed to preserve all of the treatment benefits of traditional proton therapy systems while removing the obstacles of size, cost, and complexity. Realizing this vision, Mevion has forever changed the economics and accessibility of proton therapy worldwide.Founded in 2004, Mevion is a privately held company headquartered in the Boston metropolitan area with international offices in the United Kingdom and Japan. | $45M / Jan 24, 2012 | |
|
Intuity Medical
|
Intuity Medical develops blood glucose monitoring systems for diabetes management. Their POGO Automatic Blood Glucose Monitoring System is the world’s first FDA-cleared automatic, one-step blood glucose meter that combines lancing, blood collection, and analysis into a single 10-test cartridge. It provides a convenient and discreet solution formillions of patients who need to regularly test their blood glucose.The company was founded in 2002 and is headquartered in Fremont, California. | $12M / Series D / Aug 01, 2011 | |
|
Intuity Medical
|
Intuity Medical develops blood glucose monitoring systems for diabetes management. Their POGO Automatic Blood Glucose Monitoring System is the world’s first FDA-cleared automatic, one-step blood glucose meter that combines lancing, blood collection, and analysis into a single 10-test cartridge. It provides a convenient and discreet solution formillions of patients who need to regularly test their blood glucose.The company was founded in 2002 and is headquartered in Fremont, California. | $64M / Series D / Jan 05, 2010 | |
| See all 15 investments → | |||
Co-Investors
About Acorn Bioventures
Our invest in and partner with private and small capitalization biotech, specialty pharma and medical device companies.
Acorn Bioventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Anders Hove
Partner & Founder
|
|||
Isaac Manke
Partner
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
Health Care Investors
43,014 investors
Biotech Investors
21,775 investors
Biotechnology Investors
19,370 investors
Medical Investors
18,848 investors
Health Care VC Funds
32,370 investors
Biotech VC Funds
18,864 investors
Biotechnology VC Funds
17,016 investors
Medical VC Funds
16,214 investors
Health Care Investors in United States
21,541 investors
FAQ
What does Anders Hove invest in?
Anders Hove invests primarily in Health Care, Biotechnology and Medical startups, most often at Series C and Series E stage. Most of the 15 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Anders Hove?
Public channels for Anders Hove include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Anders Hove last invest?
The most recent investment recorded for Anders Hove closed in Jan 2009. Shizune tracks 15 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
